Enhancing Anti-Myeloma Vaccine Response After Autologous Stem Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs PVX 410 (Primary) ; Influenza vaccine (Optaflu); Melphalan; Tetanus toxoid
- Indications Multiple myeloma
- Focus Therapeutic Use
- 16 Feb 2018 Planned End Date changed from 1 Jun 2019 to 1 Dec 2019.
- 16 Feb 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 16 Feb 2018 Status changed from recruiting to suspended as protocol is being modified and moved to another institution